Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Keen-Eye Technologies, commercially known as Keen Eye, is a HealthTech company established in 2015. It specializes in developing Artificial Intelligence (AI) and image analysis solutions for digital pathology. Keen Eye's platforms are designed to enhance pathology workflows, improve diagnostic accuracy, and accelerate drug development for research laboratories, pharmaceutical companies, and healthcare institutions. The company is committed to transforming tissue-based diagnostics through cutting-edge technology and deep learning algorithms.
Serves as the global headquarters, housing core functions including research and development, product innovation, corporate strategy, and international operations management.
Strategically located in Paris, a major European hub for technology and biomedical research. The office provides a modern workspace designed to foster collaboration and innovation.
Keen Eye promotes a work culture centered on innovation, scientific rigor, collaboration, and a passion for improving healthcare through technology. It's a dynamic environment focused on solving complex challenges in pathology.
The Paris headquarters is significant due to its proximity to leading research institutions, a rich talent pool, and its central role in coordinating Keen Eye's global activities and partnerships.
Keen-Eye Technologies serves a global clientele, including pharmaceutical companies, contract research organizations (CROs), and academic research institutions. While its main offices are in France, the USA, and Germany, its AI-powered digital pathology solutions are utilized by professionals worldwide. The company supports international clinical studies and research projects through its cloud-based platforms and strategic partnerships across different continents.
12 Rue de la Folie Régnault
Paris
Île-de-France
France
Address: Specific street address not publicly listed; operates within the Greater Boston biotech hub.
To establish and grow Keen Eye's presence in a key global center for life sciences innovation, providing localized support and collaboration opportunities for US-based clients.
Address: Specific street address not publicly listed; operates within the Heidelberg life science cluster.
To strengthen engagement with the European research community, particularly in Germany, and to expand Keen Eye's footprint and client base in key European markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Keen Eye by Tribun Health' leadership includes:
Keen Eye by Tribun Health has been backed by several prominent investors over the years, including:
Keen-Eye Technologies has maintained a stable core leadership team over the past 12 months, with no major C-level executive hires or departures publicly announced. This consistency supports the company's ongoing strategic initiatives and growth.
Discover the tools Keen Eye by Tribun Health uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Keen-Eye Technologies (Keen Eye) most likely utilizes common corporate email formats. Based on industry standards and their domain 'keen-eye.io', the probable primary email format is [first].[last]@keen-eye.io. Other possibilities include [first_initial][last]@keen-eye.io.
[first].[last]@keen-eye.io
Format
jane.doe@keen-eye.io
Example
85%
Success rate
Keen Eye Newsroom • October 26, 2023
Keen Eye has entered into a strategic partnership with Tribun Health to integrate their respective AI-powered digital pathology solutions. This collaboration aims to offer a comprehensive, streamlined platform for laboratories and hospitals, enhancing diagnostic workflows and improving the efficiency of pathology image analysis....more
Keen Eye Newsroom • May 23, 2023
Keen Eye announced that it has successfully obtained ISO 27001 certification. This internationally recognized standard underscores the company's commitment to maintaining the highest levels of information security management for its digital pathology solutions and protecting sensitive client data....more
Keen Eye Newsroom • March 13, 2023
Keen Eye confirmed its participation in the Digital Pathology & AI Congress Europe 2023, where it planned to showcase its latest advancements in AI-driven image analysis solutions for pathology and engage with industry leaders....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Keen Eye by Tribun Health, are just a search away.